Steps reduced for medical cannabis research
Obama’s administration recently removed an obstacle for cannabis researchers. This new legislative measure for cannabis shows that widespread use of medical cannabis by American patients is making an impact on how the government perceives MMJ.
Up until June 22, to begin a legal cannabis research trial, researchers had to follow a long and tedious four step list of procedures to procure their cannabis and licenses:
- A researcher must submit their study proposal to the FDA for approval.
- Then, they must submit their proposal to a separate Public Health Service (PHS) board.
- They must then get a marijuana permit from the Drug Enforcement Administration.
- They must obtain their desired quantity of (low grade) marijuana from the drug supply program run by the National Institute on Drug Abuse, or NIDA.
As of now, the PHS review is no longer needed by researchers to gain access to marijuana from NIDA and to get their licenses from the government. The PHS review is often a 2-4 month process, and the review can make-or-break a study application.
Learn more at http://www.drugpolicy.org/news/2015/06/obama-administration-removes-crucial-barrier-marijuana-research